JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ENTA Financials - Enanta Pharmaceuticals Income & Cash Flow | Ledgeburg
ENTA - Enanta Pharmaceuticals Inc.
USD | NASDAQ | Healthcare
Summary
Summary ENTA Stock
Financials
Financials ENTA Stock
Loading...
Loading...
Income Statement
Income Statement ENTA Stock
Balance Sheet
Balance Sheet ENTA Stock
Cash Flow Statement
Cash Flow Statement ENTA Stock
Loading...
Loading...
Home
Stocks
Enanta Pharmaceuticals Inc. (ENTA)
Financials
Financials of ENTA
Loading...
Loading...
Loading...
Loading...
Revenue
$65.324M
Operating Income
$-85.349M
Net Income
$-81.889M
Share Count (Basic)
21.336K
Operating Cash Flow
$-19.272M
Free Cash Flow
$-32.168M
Cash And Short-Term Equivalents
$32.298M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
5M
10M
15M
20M
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Q2 FY26
Annual
Quarterly
Net Income $USD
-120M
-100M
-80M
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-180%
-160%
-140%
-120%
-100%
-80%
FY2025
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-22M
-20M
-18M
-16M
-14M
-12M
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Q2 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-160%
-140%
-120%
-100%
-80%
-60%
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Q2 FY26